Bank of Montreal’s Repare Therapeutics RPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-104,919
Closed -$273K 3993
2025
Q4
$273K Hold
104,919
﹤0.01% 2654
2025
Q3
$185K Hold
104,919
﹤0.01% 2807
2025
Q2
$146K Sell
104,919
-314
-0.3% -$410 ﹤0.01% 2895
2025
Q1
$104K Sell
105,233
-8
-0% -$10 ﹤0.01% 2911
2024
Q4
$138K Sell
105,241
-6
-0% -$18 ﹤0.01% 2869
2024
Q3
$362K Sell
105,247
-5,688
-5% -$18.7K ﹤0.01% 2630
2024
Q2
$438K Buy
110,935
+5,673
+5% +$20.2K ﹤0.01% 2479
2024
Q1
$509K Buy
105,262
+300
+0.3% +$1.92K ﹤0.01% 2423
2023
Q4
$817K Sell
104,962
-1,165
-1% -$6.52K ﹤0.01% 2174
2023
Q3
$1.1M Sell
106,127
-11,697
-10% -$121K ﹤0.01% 2002
2023
Q2
$1.47M Sell
117,824
-10,003
-8% -$103K ﹤0.01% 1982
2023
Q1
$1.36M Sell
127,827
-1,000
-0.8% -$11.5K ﹤0.01% 1858
2022
Q4
$1.92M Sell
128,827
-5,068
-4% -$75.8K ﹤0.01% 1810
2022
Q3
$1.68K Sell
133,895
-3,960
-3% -$51K ﹤0.01% 1920
2022
Q2
$1.94K Sell
137,855
-800
-0.6% -$9.42K ﹤0.01% 1906
2022
Q1
$2M Buy
138,655
+49
+0% +$727 ﹤0.01% 1935
2021
Q4
$3.04M Sell
138,606
-14,682
-10% -$346K ﹤0.01% 1414
2021
Q3
$4.39M Sell
153,288
-46,100
-23% -$1.49M ﹤0.01% 1702
2021
Q2
$6.78M Sell
199,388
-57,415
-22% -$1.88M ﹤0.01% 1464
2021
Q1
$7.96M Buy
256,803
+38,636
+18% +$1.31M 0.01% 1130
2020
Q4
$9.2M Buy
218,167
+214,127
+5,300% +$6.4M 0.01% 1063
2020
Q3
$103K Buy
4,040
+3,018
+295% +$79.9K ﹤0.01% 3059
2020
Q2
$27K Buy
+1,022
New +$32.8K ﹤0.01% 3719

Bank of Montreal's RPTX Position: Q1 2026 in Review

Bank of Montreal sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 104,919 shares — an estimated $273K sold.

Bank of Montreal first reported a position in RPTX in Q2 2020 and held it in 23 quarters. The position peaked at $9.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

  • Bank of Montreal reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 104,919 Repare Therapeutics shares in Q1 2026, an estimated $273K.
  • Bank of Montreal first reported a position in Repare Therapeutics in Q2 2020 and held it in 23 quarters.
  • Bank of Montreal's Repare Therapeutics position peaked at $9.2M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.